Study Title
AREN1921: Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT)
Protocol ID
AREN1921
Condition/s
Anaplastic Kidney Wilms Tumor
Recurrent Kidney Wilms Tumor
Stage II Kidney Wilms Tumor
Stage III Kidney Wilms Tumor
Stage IV Kidney Wilms Tumor
Recurrent Kidney Wilms Tumor
Stage II Kidney Wilms Tumor
Stage III Kidney Wilms Tumor
Stage IV Kidney Wilms Tumor
Diagnosis Stage
New Diagnosis
Relapse
Relapse
Location
NSW, QLD, VIC, WA, NZ
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
Trial Status
Open
Sites
Perth Children's Hospital
Queensland Children's Hospital
Starship Hospital
The Royal Children's Hospital
The Children's Hospital at Westmead
Christchurch Hospital
John Hunter Children's Hospital
Queensland Children's Hospital
Starship Hospital
The Royal Children's Hospital
The Children's Hospital at Westmead
Christchurch Hospital
John Hunter Children's Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
up to 30 Years
International registry ID's
NCT04322318
| Study Title | AREN1921: Treatment of Newly Diagnosed Diffuse Anaplastic Wilms Tumors (DAWT) and Relapsed Favorable Histology Wilms Tumors (FHWT) |
|---|---|
| Protocol ID | AREN1921 |
| Disease (Sub Disease) | Anaplastic Kidney Wilms Tumor Recurrent Kidney Wilms Tumor Stage II Kidney Wilms Tumor Stage III Kidney Wilms Tumor Stage IV Kidney Wilms Tumor |
| Diagnosis Stage | New Diagnosis Relapse |
| Location | NSW / QLD / VIC / WA / NZ |
| Sponsor | Children's Oncology Group |
| Collaborators | National Cancer Institute (NCI) |
| Links | https://clinicaltrials.gov/ct2/show/NCT04322318 |
| Trial Status | Open |
| Trial Open Date | 18/09/2020 |
| Sites | Perth Children's Hospital/ Queensland Children's Hospital/ Starship Hospital / The Royal Children's Hospital / The Children's Hospital at Westmead / Christchurch Hospital/ John Hunter Children's Hospital |
| Study Type | Treatment |
| Phase | Phase 2 |
| Age Eligibility | up to 30 Years |
| International registry ID's | NCT04322318 |